GlassScriptPhysician profile
Stacey D Wiles
NPI 1831305242
$351.23
in general payments reported to CMS, 2019-2025
13 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.59 · 2021: $23.91 · 2022: $37.41 · 2023: $49.14 · 2024: $76.41 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $60.21 | 2024-2025 | |
| Novo Nordisk INC | $49.89 | 2024-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $39.10 | 2022-2024 | Vaxelis, Rotateq, Vaxneuvance |
| Abbvie INC. | $29.85 | 2023 | Mavyret |
| Pfizer INC. | $28.95 | 2025 | |
| Sanofi Pasteur INC. | $23.91 | 2021 | |
| Madrigal Pharmaceuticals | $19.38 | 2025 | Rezdiffra |
| Glaxosmithkline, LLC. | $19.29 | 2023 | Arexvy, Bexsero, Shingrix |
| Braeburn INC. | $19.28 | 2025 | Brixadi |
| Astrazeneca Pharmaceuticals LP | $18.59 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.53 | 2024 | |
| Cranial Technologies, INC | $14.32 | 2022 | |
| Organon LLC | $13.93 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Wiles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.